LINCS Pilot Phase Joint Project: Sensitivity measures of six breast cancer cell lines to a library of small molecule kinase inhibitors (single drug treatments). Dataset 15 of 15: Calculated dose-response metrics. - Dataset (ID:20252)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | GR_AOC |
|---|---|---|
| MCF 10A | OSI-027 | 0.5769 |
| MCF 10A | Palbociclib | 0.3786 |
| MCF 10A | PD0325901 | 0.8397 |
| MCF 10A | PD173074 | 0.0363 |
| MCF 10A | PD184352 | 0.5903 |
| MCF 10A | Pelitinib | 0.8074 |
| MCF 10A | PF431396 | 0.7656 |
| MCF 10A | PF477736 | 0.3770 |
| MCF 10A | PF562271 | 0.5425 |
| MCF 10A | PHA-665752 | 0.0608 |
| MCF 10A | PHA-793887 | 0.9167 |
| MCF 10A | PI103 | 0.5881 |
| MCF 10A | PIK-93 | 0.0969 |
| MCF 10A | PLX-4720 | 0.0137 |
| MCF 10A | QL-X-138 | 0.2745 |
| MCF 10A | QL-XII-47 | 0.3191 |
| MCF 10A | R406 | 0.1138 |
| MCF 10A | Radicicol | 0.7273 |
| MCF 10A | Sirolimus | 0.0092 |
| MCF 10A | Ruxolitinib | 0.0479 |
| MCF 10A | Saracatinib | 0.2574 |
| MCF 10A | SB590885 | 0.0517 |
| MCF 10A | Selumetinib | 0.6568 |
| MCF 10A | Sigma A6730 | 0.0796 |
| MCF 10A | Sorafenib | 0.0547 |